RETROSPECTIVE STUDY ON THE PREVALENCE OF ORAL SYMPTOMS IN THE SPECIFIC MANIFESTATIONS OF PATHOLOGY CAUSED BY SARS-CoV-2 VIRUS
Abstract
The aim of this study is to retrospectively analyze the prevalence of oral pathology in the range of symptoms characteristic of the clinical picture caused by the SARS-CoV-2 virus. The study was carried out on 779 patients with COVID-19, hospitalized between September 2020 and April 2021 in CF Hospital from Iasi, Romania. The sample’s structure on genders was almost perfectly equilibrated (49.6% men and 50.4% women), with age spread within all age ranges, between 7 and 93 years; around a half of patients were adults between 40-59 years old (45.6% men and 49.4% women). The percentage of asymptomatic patients is significantly higher among those afebrile (27.7%) compared to febrile ones (6.1%). Among the afebrile, 65.2% have 1-4 symptoms, compared to 87.7% of the febrile, and 7.1% have 5-9 symptoms, compared to 6.1% of the febrile. We noticed increased incidences of oral symptoms in patients with aggravated condition (febrile) by comparison with the others, in most cases - with only one exception, gum bleeding, which is slightly more frequent in case of afebrile / sub febrile patients (59.2% cases compared with 55.1% cases of febrile patients). Oral signs including dysgeusia, xerostomia, oral mucosal lesions and periodontal pathology could be associated with SARS-CoV-2 infection or equally could be considered secondary lesions of COVID19 infection, which are extremely useful elements in the early diagnosis of people with COVID19.
References
2. Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: Tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS chem. Neuroscience 2020; 11: 995-998.
3. Capaccio P, Pignataro L, Corbellino M, Popescu-Dutruit S, Torretta S. Acute parotitis: A possible precocious clinical manifestation of SARS-CoV-2 Infection? Otolaryngol. Head Neck Surg 2020; 163: 182-183.
4. Doyle ME, Appleton A, Liu QR, Yao Q, Mazucanti CH, Egan JM. Human type II taste cells express angiotensin-converting enzyme 2 and are infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Am J Pathol 2021; 191: 1511-1519.
5. Drozdzik A, Drozdzik M. Oral pathology in COVID-19 and SARS-CoV-2 infection-molecular as-pects. Int. J. Mol. Sci. 2022; 23: 1431-1435.
6. Erbaş GS, Botsali A, Erden N, et al. COVID-19-related oral mucosa lesions among confirmed SARS-CoV-2 patients: A systematic review. Int J Dermatol 2022; 61: 20-32.
7. Gorbalenya AE, Baker S, Baric RS, al. The species Severe acute respiratory syndrome-related coro-navirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020; 5: 536-544.
8. Gupta S, Mohindra R, Chauhan PK, et al. SARS-CoV-2 detection in gingival crevicular fluid. J. Dent. Res 2021; 100 :187-193.
9. Herrera D, Serrano J, Roldán S, Sanz M. Is the oral cavity relevant in SARS-CoV-2 pandemic? Clin. Oral Investig 2020; 24: 2925-2930.
10. Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2022; 181: 271-280.
11. Isho B, Abe KT, Zuo M, et al. Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients. Sci. Immunol 2021; 5: 5511.
12. Kumar S. Could the oral cavity be a target organ in SARS-CoV-2 infection? Evid. Based Dent. 2021; 22: 78-79.
13. La Rosa GRM, Libra M, De Pasquale R, Ferlito S, Pedullà E. Association of viral infections with oral cavity lesions: Role of SARS-CoV-2 infection. Front. Med. 2021; 7: 571214.
14. Lechien JR, Chetrit A, Chekkoury-Idrissi Y, et al. Parotitis-like symptoms associated with COVID-19, France, March-April 2020. Emerg. Infect Dis 2020; 26: 2270-2271.
15. Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003; 426: 450-454.
16. Mahmoud MM, Abuohashish HM, Khairy DA, Bugshan AS, Khan AM, Moothedath MM. Pathogen-esis of dysgeusia in COVID-19 patients: A scoping review. Eur Rev Med Pharmacol Sci 2021; 25: 1114-1134.
17. Mehraeen E, Behnezhad F, Salehi MA, Noori T, Harandi H, Seyed A, Alinaghi S. Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): A review of current evidence. Eur. Arch. Otorhinolaryngol 2021; 278; 307-312.
18. Mohseni Afshar Z, Barary M, Ebrahimpour S, et al. Pathophysiology and management of tongue involvement in COVID-19 patients. Indian J Otolaryngol Head Neck Surg 2022; 74: 3235-3238.
19. Nagaoka K, Yanagihara K, Morinaga Y, et al. Prevotella intermedia induces severe bacteremic pneumococcal pneumonia in mice with upregulated platelet-activating factor receptor expression. Infect. Immun 2014; 82: 587-593.
20. Papageorgiou AC, Mohsin I. The SARS-CoV-2 spike glycoprotein as a drug and vaccine target: Structural insights into its complexes with ACE2 and antibodies. Cells 2020; 9: 2343.
21. Shen Z, Xiao Y, Kang L, et al. Genomic diversity of severe acute respiratory syndrome-coronavirus 2 in patients with coronavirus disease 2019. Clin Infect Dis 2020; 71: 713-720.
22. Silveira FM, Mello ALR, da Silva Fonseca L, et al. Morphological and tissue-based molecular char-acterization of oral lesions in patients with COVID-19: A living systematic review. Arch. Oral Bi-ol. 2022;136: 105374-105374.
23. Tsukinoki K, Yamamoto T, Handa K, et al. Detection of cross-reactive immunoglobulin an against the severe acute respiratory syndrome-coronavirus-2 spike 1 subunit in saliva. PLoS One. 2021;16: 249979.
24. Vaz SN, Santana DS, Netto EM, et al. Saliva is a reliable, non-invasive specimen for SARS-CoV-2 detection. Braz. J. Infect. Dis. 2020; 24: 422-427.
25. Viner RM, Whittaker E. Kawasaki-like disease: Emerging complication during the COVID-19 pan-demic. Lancet. 2020; 395: 1741-1743.
26. Amorim dos Santos J, Normando AG, Carvalho da Silva RL, et al. Oral manifestations in patients with COVID-19: A 6-month update. J. Dent. Res 2021; 100: 1321-1329.
27. Gherlone EF, Polizzi E, Tetè G, et al. Frequent and persistent salivary gland ectasia and oral disease After COVID-19. J Dent. Res. 2021; 100: 464-471.
28. Brandão TB, Gueiros LA, Melo TS, et al. Oral lesions in patients with SARS-CoV-2 infection: Could the oral cavity be a target organ? Oral Surg Oral Med Oral Pathol Oral Radiol 2021; 31: 45-51.
Additional Files
Published
Issue
Section
License
COPYRIGHT
Once an article is accepted for publication, MSJ requests a transfer of copyrights for published articles.
COPYRIGHT TRANSFER FORM FOR
REVISTA MEDICO-CHIRURGICALĂ A SOCIETĂȚII DE MEDICI ȘI NATURALIȘTI DIN IAȘI /
THE MEDICAL-SURGICAL JOURNAL OF THE SOCIETY OF PHYSICIANS AND NATURALISTS FROM IASI
We, the undersigned authors of the manuscript entitled
_____________________________________________________________________________________
_____________________________________________________________________________________
warrant that this manuscript, which is submitted for publication in the REVISTA MEDICO-CHIRURGICALĂ, has not been published and it is not under consideration for publication in another journal.
- we give the consent for publication in the REVISTA MEDICO-CHIRURGICALĂ, in printed and electronic format and we transfer unconditioned and complete the copyright of this manuscript to the REVISTA MEDICO-CHIRURGICALĂ, in the event of its acceptance.
- the manuscript does not break the intellectual property rights of any other person.
- we have read the submitted version of the manuscript and we are fully responsible for the content.
Names and signatures of authors / copyright owners (the following sequence is the authorship of the article):
- ______________________________/_________________________
- ______________________________/_________________________
- ______________________________/_________________________
N.B. All the authors must sign this form
